About UCSF Search UCSF UCSF Medical Center

News

image

Brain Tumor Patient Benefits from Technology

June 25, 2006

Sasha Cano thought she was dreaming: she woke up in an ambulance and was told that she was being taken to the emergency room. "When they told me I had had a seizure, I didn't believe them," Cano recalls, who in December 2003, awoke from ...
image

McEvoy Bequest Names Diller Cancer Research Building Lobby

June 22, 2006

Third-generation San Franciscans, Jay, Clare, and Alicia McEvoy had a passion for philanthropy. Never marrying, the siblings spent their lives together in the Sea Cliff home built for their parents, devoting their energy to local organizations such as St. Monica's Church, the Schools of the ...
image

Employee Well-Being Program Implemented in Cancer Center

June 21, 2006

Margaret Rubino, a patient care coordinator in the UCSF Comprehensive Cancer Center, often feels stressed and emotionally drained after dealing with cancer patients day in and day out. "Sometimes you want to cry, because the stories are so heartbreaking," said Rubino. "Much of our job ...
image

Fellow Receives Pediatrics' Grumbach Award

June 20, 2006

UCSF pediatric oncology-hematology fellow Jennifer Lauchle, MD, has received the 2006 Melvin Grumbach Award for Pediatric Research for her work on modeling the genetics of acute myeloid leukemia. Lauchle's research has the long-term goal of developing more targeted and effective therapies for acute myeloid leukemia, ...
image

O'Farrell's Gels Blazed New Pathways

May 22, 2006

More than 30 years ago, when still a graduate student at University of Colorado, UCSF biochemist Patrick O'Farrell, PhD, invented a way to separate proteins from one another in biological samples, a technique called high-resolution two-dimensional gel electrophoresis. The technique underlies much of modern biomedical ...
image

New Compound Unusually Potent at Blocking Brain Cancer Growth

May 15, 2006

By determining how a class of compounds blocks signaling in cells, UCSF scientists have identified what is perhaps the most potent drug candidate yet against a highly lethal kind of brain tumor. The compound, known as PI-103, shows unique potency against cancer cell proliferation in ...